Compare Stocks

Date Range: 

 Utah Medical ProductsThe WestaimDarioHealthCytosorbentsApyx Medical
SymbolNASDAQ:UTMDOTCMKTS:WEDXFNASDAQ:DRIONASDAQ:CTSONASDAQ:APYX
Price Information
Current Price$86.24$2.04$15.37$7.44$9.48
50-Day Moving Average$85.38$2.18$18.90$7.97$9.99
52-Week Low$77.22$1.46$7.00$7.13$4.35
52-Week High$95.64$2.36$31.85$11.68$12.01
MarketRank™
Overall Score0.81.41.51.71.5
Analysis Score0.03.53.43.53.5
Community Score2.12.72.63.52.6
Dividend Score0.00.00.00.00.0
Ownership Score1.70.00.80.80.8
Earnings & Valuation Score0.00.60.60.60.6
Analyst Ratings
Consensus RecommendationN/ABuyBuyBuyBuy
Consensus Price TargetN/A$4.15$26.38$15.67$13.00
% Upside from Price TargetN/A103.26% upside71.60% upside110.57% upside37.13% upside
Trade Information
Market Cap$314.78 million$292.35 million$238.85 million$322.30 million$325.35 million
Beta0.250.711.340.280.75
Average Volume11,29452,803283,884311,805129,888
Sales & Book Value
Annual Revenue$42.18 million$24.85 million$7.58 million$41.01 million$27.71 million
Price / Sales7.4611.7631.517.8611.74
Cashflow$5.01 per share$0.04 per shareN/AN/AN/A
Price / Cash17.2157.23N/AN/AN/A
Book Value$28.25 per share$2.24 per share$3.47 per share$1.83 per share$1.86 per share
Price / Book3.050.914.434.075.10
Profitability
Net Income$10.80 million$-34,400,000.00$-29,440,000.00$-7,840,000.00$-11,900,000.00
EPSN/AN/A($4.01)($0.20)($0.57)
Trailing P/E Ratio29.53N/AN/AN/AN/A
Forward P/E RatioN/A82.67N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins25.29%-219.20%-370.22%-19.94%-47.35%
Return on Equity (ROE)10.65%4.40%-74.88%-13.11%-24.39%
Return on Assets (ROA)9.78%3.78%-64.48%-10.34%-20.86%
Dividend
Annual Payout$1.14N/AN/AN/AN/A
Dividend Yield1.32%N/AN/AN/AN/A
Three-Year Dividend Growth5.63%N/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend Growth1 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.12%N/AN/AN/A
Current Ratio14.59%0.63%7.52%8.16%6.48%
Quick Ratio13.28%0.63%7.09%7.84%6.02%
Ownership Information
Institutional Ownership Percentage72.29%0.01%35.18%40.03%55.27%
Insider Ownership Percentage7.00%4.21%21.20%5.70%10.00%
Miscellaneous
Employees1817127195266
Shares Outstanding3.65 million143.19 million15.54 million43.32 million34.32 million
Next Earnings Date10/26/2021 (Estimated)8/12/2021 (Estimated)8/11/2021 (Estimated)8/3/2021 (Confirmed)8/12/2021 (Confirmed)
OptionableNot OptionableNot OptionableNot OptionableOptionableOptionable
SourceHeadline
Comparing Apyx Medical (NASDAQ:APYX) & Axonics (NASDAQ:AXNX)Comparing Apyx Medical (NASDAQ:APYX) & Axonics (NASDAQ:AXNX)
americanbankingnews.com - July 20 at 1:14 AM
Were Hopeful That Apyx Medical (NASDAQ:APYX) Will Use Its Cash WiselyWe're Hopeful That Apyx Medical (NASDAQ:APYX) Will Use Its Cash Wisely
finance.yahoo.com - July 14 at 6:28 AM
Apyx Medical Corporation to Release Second Quarter…Apyx Medical Corporation to Release Second Quarter…
pharmiweb.com - July 12 at 7:35 PM
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021
finance.yahoo.com - July 12 at 4:53 PM
Apyx Medical (NASDAQ:APYX) Earns "Buy" Rating from Colliers SecuritiesApyx Medical (NASDAQ:APYX) Earns "Buy" Rating from Colliers Securities
americanbankingnews.com - June 28 at 8:58 AM
Apyx Medical Corporation (APYX)Apyx Medical Corporation (APYX)
finance.yahoo.com - June 18 at 12:09 AM
Paratek Appoints Minnie Baylor-Henry to Company’s Board of DirectorsParatek Appoints Minnie Baylor-Henry to Company’s Board of Directors
in.finance.yahoo.com - June 14 at 8:57 AM
Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion ® in Dermal Resurfacing ProceduresApyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion ® in Dermal Resurfacing Procedures
businesswire.com - June 1 at 9:49 AM
Is Apyx Medical Corporation (NASDAQ:APYX) Popular Amongst Insiders?Is Apyx Medical Corporation (NASDAQ:APYX) Popular Amongst Insiders?
nasdaq.com - June 1 at 8:11 AM
Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion® in Dermal Resurfacing ProceduresApyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion® in Dermal Resurfacing Procedures
finance.yahoo.com - June 1 at 8:11 AM
ROCE Insights For Apyx MedicalROCE Insights For Apyx Medical
benzinga.com - May 26 at 1:32 PM
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue EstimatesApyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 12 at 1:17 PM
BRIEF-Apyx Medical Corp. Reports Q1 Revenue Of $8.6 MlnBRIEF-Apyx Medical Corp. Reports Q1 Revenue Of $8.6 Mln
msn.com - May 12 at 8:15 AM
Apyx: Q1 Earnings Snapshot | Raleigh News & ObserverApyx: Q1 Earnings Snapshot | Raleigh News & Observer
newsobserver.com - May 12 at 8:15 AM
Apyx: Q1 Earnings SnapshotApyx: Q1 Earnings Snapshot
greenwichtime.com - May 12 at 8:15 AM
Apyx Medical Corporation Reports First Quarter 2021 Financial Results and Updates Full Year 2021 OutlookApyx Medical Corporation Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Outlook
finance.yahoo.com - May 12 at 8:15 AM
Could The Apyx Medical Corporation (NASDAQ:APYX) Ownership Structure Tell Us Something Useful?Could The Apyx Medical Corporation (NASDAQ:APYX) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - May 11 at 8:51 AM
Cold Plasma Market SWOT Analysis by Key Players: Tantec, Europlasma, ThierryCold Plasma Market SWOT Analysis by Key Players: Tantec, Europlasma, Thierry
sbwire.com - April 30 at 12:46 PM
Apyx Medical Corporation to Release First Quarter…Apyx Medical Corporation to Release First Quarter…
pharmiweb.com - April 12 at 8:00 PM
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021Apyx Medical Corporation to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021
finance.yahoo.com - April 12 at 8:00 PM
Apyx Medical Corporation (APYX) CEO Charlie Goodwin on Q4 2020 Results - Earnings Call TranscriptApyx Medical Corporation (APYX) CEO Charlie Goodwin on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - April 2 at 10:32 AM
Apyx Medical Corporation (NASDAQ:APYX) Just Reported And Analysts Have Been Lifting Their Price TargetsApyx Medical Corporation (NASDAQ:APYX) Just Reported And Analysts Have Been Lifting Their Price Targets
nasdaq.com - April 2 at 9:27 AM
Apyx Medical: Q4 Earnings InsightsApyx Medical: Q4 Earnings Insights
benzinga.com - March 31 at 10:48 AM
BRIEF-Apyx Medical Sees FY 2021 Revenue $36.7 Mln To $38.7 MlnBRIEF-Apyx Medical Sees FY 2021 Revenue $36.7 Mln To $38.7 Mln
msn.com - March 31 at 10:48 AM
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue EstimatesApyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - March 31 at 10:48 AM
DateCompanyBrokerageAction
6/28/2021Apyx MedicalColliers Securities
Reiterated Rating
5/24/2021DarioHealthAlliance Global Partners
Lower Price Target
5/18/2021DarioHealthStifel Nicolaus
Lower Price Target
4/22/2021DarioHealthCowen
Initiated Coverage
3/30/2021Apyx MedicalColliers Securities
Reiterated Rating
3/22/2021DarioHealthStifel Nicolaus
Initiated Coverage
2/25/2021DarioHealthCantor Fitzgerald
Initiated Coverage
2/8/2021DarioHealthAegis
Boost Price Target
2/1/2021DarioHealthAlliance Global Partners
Downgrade
1/29/2021Apyx MedicalPiper Sandler
Boost Price Target
1/7/2021The WestaimStifel Nicolaus
Boost Price Target
1/4/2021CytosorbentsB. Riley
Boost Price Target
9/17/2020CytosorbentsJefferies Financial Group
Initiated Coverage
9/1/2020CytosorbentsSVB Leerink
Initiated Coverage
8/17/2020DarioHealthAegis
Initiated Coverage
8/13/2020DarioHealthCraig Hallum
Boost Price Target
7/23/2020CytosorbentsB. Riley
Reiterated Rating
6/22/2020DarioHealthThinkEquity
Initiated Coverage
6/12/2020CytosorbentsB. Riley
Initiated Coverage
5/13/2020DarioHealthCraig Hallum
Boost Price Target
5/12/2020Apyx MedicalJMP Securities
Lower Price Target
5/7/2020CytosorbentsMaxim Group
Initiated Coverage
5/6/2020CytosorbentsHC Wainwright
Boost Price Target
5/6/2020CytosorbentsB. Riley
Boost Price Target
4/16/2020CytosorbentsHC Wainwright
Reiterated Rating
3/26/2020CytosorbentsMaxim Group
Reiterated Rating
3/18/2020DarioHealthCraig Hallum
Lower Price Target
3/17/2020Apyx MedicalPiper Sandler
Lower Price Target
3/9/2020CytosorbentsDawson James
Reiterated Rating
3/6/2020CytosorbentsHC Wainwright
Reiterated Rating
12/4/2019DarioHealthCraig Hallum
Lower Price Target
11/27/2019CytosorbentsB. Riley
Reiterated Rating
11/26/2019CytosorbentsHC Wainwright
Reiterated Rating
11/25/2019CytosorbentsMaxim Group
Reiterated Rating
11/11/2019Apyx MedicalPiper Jaffray Companies
Boost Price Target
10/21/2019CytosorbentsB. Riley
Set Price Target
8/7/2019CytosorbentsHC Wainwright
Reiterated Rating
8/7/2019CytosorbentsMaxim Group
Set Price Target
7/19/2019CytosorbentsB. Riley
Set Price Target
6/6/2019DarioHealthCraig Hallum
Initiated Coverage
5/8/2019CytosorbentsMaxim Group
Set Price Target
5/8/2019Apyx MedicalPiper Jaffray Companies
Lower Price Target
4/2/2019Apyx MedicalDougherty & Co
Lower Price Target
4/2/2019Apyx MedicalJMP Securities
Lower Price Target
3/8/2019CytosorbentsMaxim Group
Reiterated Rating
3/8/2019CytosorbentsHC Wainwright
Reiterated Rating
2/11/2019Apyx MedicalPiper Jaffray Companies
Boost Price Target
1/14/2019CytosorbentsHC Wainwright
Set Price Target
12/20/2018CytosorbentsMaxim Group
Set Price Target
11/7/2018CytosorbentsHC Wainwright
Set Price Target
9/14/2018Apyx MedicalDougherty & Co
Reiterated Rating
(Data available from 7/23/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.